Cartesian Therapeutics, Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Cartesian Therapeutics, Inc. (RNAC) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2026-03-09
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-12-31 was $0.00.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-09-30 was $0.00.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-06-30 was $0.00.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-03-31 was $0.00.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2025 was $0.00.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2024 was -$6.89M.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was -$149.60M.
- Cartesian Therapeutics, Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2022 was $0.00.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | -$6.89M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | -$6.89M 10-Q · filed 2025-11-06 | -$156.49M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | -$6.89M 10-Q · filed 2025-08-07 | -$156.49M derived: sum of 3 quarters · filed 2025-08-07 | -$156.49M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$6.89M 10-Q · filed 2025-05-08 | -$156.49M derived: sum of 2 quarters · filed 2025-05-08 | -$156.49M derived: sum of 3 quarters · filed 2025-05-08 | -$156.49M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$149.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$149.60M derived: sum of 2 quarters · filed 2025-03-13 | -$149.60M derived: sum of 3 quarters · filed 2025-03-13 | -$149.60M 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |